The shift in the extinction maximum, λmax, of the localized surface plasmon resonance (LSPR) spectrum of
triangular Ag nanoparticles (∼90 nm wide and 50 nm high) is used to probe the interaction between a surface-confined antigen, biotin (B), and a solution-phase antibody, anti-biotin (AB). Exposure of biotin-functionalized
Ag nanotriangles to 7 × 10-7 M < [AB] < 7 × 10-6 M caused a ∼38 nm red-shift in the LSPR λmax. The
experimental normalized response of the LSPR λmax shift, (ΔR/ΔR
max), versus [AB] was measured over the
concentration range 7 × 10-10 M < [AB] < 7 × 10-6 M. Comparison of the experimental data with the
theoretical normalized response for a 1:1 binding model yielded values for the saturation response, ΔR
max =
38.0 nm, the surface-confined thermodynamic binding constant, K
a,surf = 4.5 × 107 M-1, and the limit of
detection (LOD) < 7 × 10-10 M. The experimental saturation response was interpreted in terms of a closest-packed structural model for the surface B−AB complex in which the long axis of AB, l
AB = 15 nm, is
oriented horizontally and the short axis, h
AB = 4 nm is oriented vertically to the nanoparticle surface. This
model yields a quantitative response for the saturation response, ΔR
max = 40.6 nm, in good agreement with
experiment, ΔR
max = 38.0 nm. An atomic force microscopy (AFM) study supports this interpretation. In
addition, major improvements in the LSPR nanobiosensor are reported. The LSPR nanobiosensor substrate
was changed from glass to mica, and a surfactant, Triton X-100, was used in the nanosphere lithography
fabrication procedure. These changes increased the adhesion of the Ag nanotriangles by a factor of 9 as
determined by AFM normal force studies. The improved adhesion of Ag nanotriangles now enables the study
of the B−AB immunoassay in a physiologically relevant fluid environment as well as in real-time. These
results represent important new steps in the development of the LSPR nanosensor for applications in medical
diagnostics, biomedical research, and environmental science.
LP-PRP results in improved functional outcome scores compared with hyaluronic acid and placebo when used for treatment of knee osteoarthritis. LP-PRP and LR-PRP have similar safety profiles, although both induce more transient reactions than does hyaluronic acid. Adverse reactions to PRP may not be directly related to leukocyte concentration.
This article reports the first hydrogel with the strength and modulus of cartilage in both tension and compression, and the first to exhibit cartilage‐equivalent tensile fatigue strength at 100 000 cycles. These properties are achieved by infiltrating a bacterial cellulose (BC) nanofiber network with a poly(vinyl alcohol) (PVA)–poly(2‐acrylamido‐2‐methyl‐1‐propanesulfonic acid sodium salt) (PAMPS) double network hydrogel. The BC provides tensile strength in a manner analogous to collagen in cartilage, while the PAMPS provides a fixed negative charge and osmotic restoring force similar to the role of aggrecan in cartilage. The hydrogel has the same aggregate modulus and permeability as cartilage, resulting in the same time‐dependent deformation under confined compression. The hydrogel is not cytotoxic, has a coefficient of friction 45% lower than cartilage, and is 4.4 times more wear‐resistant than a PVA hydrogel. The properties of this hydrogel make it an excellent candidate material for replacement of damaged cartilage.
The quality of the evidence comparing inside-out and all-inside meniscal repair remains low, with a majority of the literature being evidence level 4 studies. In this review comparing modern all-inside devices with inside-out repair, no differences were seen in failure rates, functional outcome scores, or complication rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.